Overview A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis Status: Completed Trial end date: 2011-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis. Phase: Phase 2 Details Lead Sponsor: Kowa Research Institute, Inc.